| Financial Year |
March 31 2023 |
| Monetary Funds |
393,382,291.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,627,220.78 |
| Accounts Receivable |
170,839,608.05 |
| Advances to Suppliers |
48,593,485.83 |
| Other Receivables |
14,581,225.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
274,863,212.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,050,790.64 |
| Total Current Assets |
925,013,787.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,388,919.59 |
| Investment Properties |
25,838,213.92 |
| Fixed Assetes |
170,900,742.93 |
| Under-construction Projects |
762,408.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,629,836.36 |
| R&D expenses |
5,170,577.42 |
| Goodwill |
361,579,864.24 |
| Long-Term Deferred and Prepaid Expenses |
25,105,798.59 |
| Deferred Income Tax Assets |
13,731,365.99 |
| Other Non-Current Assets |
1,471,322.00 |
| Sub-Total of Non-Current Assets |
714,598,700.03 |
| Total Assets |
1,639,612,487.86 |
| Short-Term Loans |
62,809,698.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
71,882,680.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,260,700.76 |
| Taxes Payable |
6,667,894.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,626,152.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,654,801.80 |
| Other Current Liabilities |
17,067,870.43 |
| Sub-Total of Current Liabilities |
339,791,357.84 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,365,067.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
43,731,865.00 |
| Total Liabilities |
383,523,222.84 |
| Paid-In Capital(Or Share Stock) |
200,840,639.00 |
| Capital Surplus |
770,386,916.95 |
| Surplus Reserve |
14,952,343.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
255,772,033.82 |
| Minority Stockholder's Interest |
8,922,699.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,247,166,565.57 |
| Owner's Equity（Stockholder's Equity） |
1,256,089,265.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,639,612,487.86 |
